The surgical point of view about persistent air leaks: prevention first by Venuta, Federico et al.
the authors aware of any evidence that this sealing of
the pleural space has ever occurred, let alone that this
action has been the mechanism behind the “clinical”
success of all such procedures? The pleural changes
reported at subsequent thoracotomy or postmortem
examination, following previous “clinically successful
pleurodesis,” have been clearly described and accepted;
that is, pleural thickening associated with fibrin
production, collagen deposition and fibrosis, plus
variable adhesions. However, despite the very large
number of “clinically successful pleurodeses” achieved
over the last 80 years, there appear to be no similar
reports demonstrating sealing or obliteration of the
pleural cavity. It should be remembered that pleural
adhesions do not prevent tethered pneumothoraces in
the case of air leaks (or loculated effusions associated
with pleural malignancy). In an age of evidence-based
medicine, such an absence of evidence suggests a
medical myth. Should the “success” of the procedure be
more accurately attributed to those pleural changes that
we know do occur?
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About Persistent Air Leaks
Prevention First!
To the Editor:
We read with interest the paper by Dugan et al1
recently published in CHEST (August 2017) about the
management of persistent air leaks (PAL). We have
appreciated the attention of CHEST regarding this
complication that affects numerous pulmonary
patients and which represents a daily challenge for
thoracic surgeons. The review performed by the
authors is exhaustive, including different aspects of1352 Correspondencethe problem and reporting the most popular
therapeutic strategies to solve it.2,3 However, the first
lesson learned in the operating theater is that
“prevention is better than cure.” Thus, a careful
intraoperative management of pulmonary
parenchyma should be stressed because it represents
the most efficient strategy to prevent PAL. The
manipulation of the pulmonary parenchyma during
surgery, in particular when marked pleural adhesions
are present or in the case of emphysematous lungs,
might be gentle to avoid air leakage.
One of the most important risk factors for the
development of PAL in patients undergoing lobectomy
is the absence of interlobar fissures, which eventuality
obliges surgeons to work inside the parenchyma to reach
the interlobar branches of the pulmonary artery, often
creating minor damage to the remaining lobe. It could
be resolved by using specific surgical techniques such as
fissure-less lobectomy (the separation of fissures with
mechanical staplers occurs after the resection of vascular
and bronchial elements).4 This technique is almost
always used during video-assisted lobectomy. In the case
of lung volume reduction surgery or wedge resections
performed in patients with other underlying pulmonary
disease (eg, idiopathic pulmonary fibrosis), it could be
helpful to use patches of pericardial tissue to wrap the
loads of staplers and thus reinforce the staple lines.
Furthermore, numerous sealants and glues are routinely
used to cover lung parenchyma to avoid PAL, in
particular when microlesions on the visceral pleural
surface are present.5 Although these precautions do not
eliminate the problem of PAL (they must be treated, as
reported in the review1), they dramatically decrease the
incidence of PAL, with better postoperative recovery as
well as a reduction in health costs.Federico Venuta, MD
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Pulmonary Embolism
Response Team Is Activated
Affect Time to Intervention
or Outcome?
To the Editor:
In this letter, we evaluate how the activation time of the
Pulmonary Embolism Response Team affects treatment
decisions and time to intervention. Prior studies have
demonstrated higher mortality rates for patients who
originally presented with acute pulmonary embolism
(PE) on a weekend as well as diverging survival curves
after the first day of care, highlighting that early
decision-making regarding treatment for PE may affectTABLE 1 ] Characteristics of Day and Night Groups
Variable
All patients
Age, mean (SD), y
Female sex, No. (%)
Race, No. (%)
White
African American
Asian
Hispanic
Other
Highest heart rate, mean (SD), beats/min
Lowest systolic blood pressure, mean (SD), mm Hg
Highest respiratory rate, mean (SD), breaths/min
Troponin value, median (Q1-Q3), ng/mL 0.0
BNP value, median (Q1-Q3), pg/mL 87
Simplified PESI score, median (Q1-Q3)
30-day mortality, No. (%)
BNP ¼ brain natriuretic peptide, PESI ¼ Pulmonary Embolism Severity Index.
chestjournal.org30-day mortality.1,2 We evaluate how day and night
groups, or “on-hours” and “off-hours” activations, could
contribute to different treatment decisions as well as
different times to intervention and 30-day mortality.
Of the 457 Pulmonary Embolism Response Team
activations at the Massachusetts General Hospital, 317
occurred during the day and 140 during the night.
Table 1 describes the demographics of the patients as
well as characteristics at time of presentation. The day
and night patients were similar in, sex, PE severity, and
other clinical characteristics.3 The data collection and
analysis was approved by the Human Research
Committee of Partners Health Care (protocol No.
2012P002257).
We found no difference in the rate of interventions
within 24 hours of activation between the day and night
groups (13% vs 15%; P ¼ .62). Among those who
received interventions within 24 hours, the distribution
for the type of intervention was slightly different
between the two groups: Catheter-directed therapy
accounted for 81% of interventions in the night group
but only 55% of interventions in the day group, and
systemic IV thrombolysis and surgical embolectomy
were more common in the day group (P ¼ .06) (Fig 1).
When limited to interventions that occurred within 6
hours (early intervention), the distribution of the type of
intervention was similar between the two groups
(P ¼ .99). Among those who received interventionsDay Night P Value
n ¼ 317 n ¼ 140 .
62 (16) 61 (15) .50
140 (44) 71 (51) .20
266 (84) 108 (77) .16
25 (8) 13 (9)
4 (1) 3 (2)
8 (3) 2 (1)
14 (4) 14 (10)
106 (22) 107 (23) .74
115 (24) 115 (21) .76
22 (5) 23 (7) .14
3 (0.01-0.12) 0.04 (0.01-0.11) .30
7 (215-3001) 1313 (356-3810) .93
1 (1-2) 1 (0-2) .81
36 (12) 19 (16) .32
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